SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001520138-24-000092
Filing Date
2024-03-04
Accepted
2024-03-04 17:28:48
Documents
22
Period of Report
2024-03-04
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT AMENDMENT NO.1 bivi-20240304_8ka1.htm   iXBRL 8-K/A 27853
2 EXHIBIT 5.1 bivi-20240304_ex5z1.htm EX-5.1 22652
3 EXHIBIT 5.2 bivi-20240304_ex5z2.htm EX-5.2 16170
7 GRAPHIC image_001.jpg GRAPHIC 17379
8 GRAPHIC image_002.jpg GRAPHIC 51813
9 GRAPHIC image_003.jpg GRAPHIC 15211
10 GRAPHIC image_004.jpg GRAPHIC 58450
11 GRAPHIC image_006.jpg GRAPHIC 8114
12 GRAPHIC image_005.jpg GRAPHIC 8114
  Complete submission text file 0001520138-24-000092.txt   475154

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE bivi-20240304.xsd EX-101.SCH 3027
5 XBRL LABEL FILE bivi-20240304_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE bivi-20240304_pre.xml EX-101.PRE 22367
23 EXTRACTED XBRL INSTANCE DOCUMENT bivi-20240304_8ka1_htm.xml XML 4777
Mailing Address 680 W NYE LANE SUITE 201 CARSON CITY NV 89703
Business Address 680 W NYE LANE SUITE 201 CARSON CITY NV 89703 775-888-3162
BIOVIE INC. (Filer) CIK: 0001580149 (see all company filings)

IRS No.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K/A | Act: 34 | File No.: 001-39015 | Film No.: 24716248
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)